Literature DB >> 11076668

The incidence of breast cancer in the General Practice Research Database compared with national cancer registration data.

J A Kaye1, L E Derby, M del Mar Melero-Montes, M Quinn, H Jick.   

Abstract

Breast cancer incidence rates in the UK from 1990 to 1996 among women aged 35-69 estimated from the General Practice Research Database (GPRD) were closely similar to those reported by the Office for National Statistics from cancer registration data (ONS). The GPRD is a valuable and up-to-date resource for further study of the incidence of breast cancer in the UK as well as changes in cancer treatment and their relation to survival trends. Copyright 2000 Cancer Research Campaign.

Entities:  

Mesh：

Year:  2000        PMID： 11076668      PMCID： PMC2363417          DOI： 10.1054/bjoc.2000.1493

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  17 in total

Review 1.  Systematic review of scope and quality of electronic patient record data in primary care.

Authors:  Krish Thiru; Alan Hassey; Frank Sullivan
Journal:  BMJ       Date:  2003-05-17

2.  Incidence and prevalence of drug-treated attention deficit disorder among boys in the UK.

Authors:  Hershel Jick; James A Kaye; Corri Black
Journal:  Br J Gen Pract       Date:  2004-05       Impact factor: 5.386

3.  Consultations for middle ear disease, antibiotic prescribing and risk factors for reattendance: a case-linked cohort study.

Authors:  Ian Williamson; Sarah Benge; Mark Mullee; Paul Little
Journal:  Br J Gen Pract       Date:  2006-03       Impact factor: 5.386

4.  Long-term metformin use is associated with decreased risk of breast cancer.

Authors:  Michael Bodmer; Christian Meier; Stephan Krähenbühl; Susan S Jick; Christoph R Meier
Journal:  Diabetes Care       Date:  2010-03-18       Impact factor: 19.112

5.  A case control study of age related macular degeneration and use of statins.

Authors:  L Smeeth; C Cook; U Chakravarthy; R Hubbard; A E Fletcher
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

Review 6.  Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research.

Authors:  Nicole Gray Weiskopf; Chunhua Weng
Journal:  J Am Med Inform Assoc       Date:  2012-06-25       Impact factor: 4.497

7.  Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data.

Authors:  M P Coleman; D Forman; H Bryant; J Butler; B Rachet; C Maringe; U Nur; E Tracey; M Coory; J Hatcher; C E McGahan; D Turner; L Marrett; M L Gjerstorff; T B Johannesen; J Adolfsson; M Lambe; G Lawrence; D Meechan; E J Morris; R Middleton; J Steward; M A Richards
Journal:  Lancet       Date:  2010-12-21       Impact factor: 79.321

8.  Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer.

Authors:  L Huiart; S Dell'Aniello; S Suissa
Journal:  Br J Cancer       Date:  2011-04-26       Impact factor: 7.640

9.  Evidence against the proposition that "UK cancer survival statistics are misleading": simulation study with National Cancer Registry data.

Authors:  Laura M Woods; Michel P Coleman; Gill Lawrence; Jem Rashbass; Franco Berrino; Bernard Rachet
Journal:  BMJ       Date:  2011-06-09

10.  The incidence of and mortality from leukaemias in the UK: a general population-based study.

Authors:  Fatima Bhayat; Emma Das-Gupta; Chris Smith; Tricia McKeever; Richard Hubbard
Journal:  BMC Cancer       Date:  2009-07-26       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.